4//SEC Filing
Kuriakose Emil 4
Accession 0001562180-25-000852
CIK 0001831363other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:27 PM ET
Size
5.8 KB
Accession
0001562180-25-000852
Insider Transaction Report
Form 4
Kuriakose Emil
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-30+485,000→ 485,000 totalExercise: $4.64Exp: 2035-01-29→ Common Stock (485,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001892413
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:27 PM ET
- Size
- 5.8 KB